T-Cell Receptor-Stimulated Calcineurin Activity Is Inhibited in Isolated T Cells from Transplant Patients
AUTOR(ES)
Tumlin, James A.
FONTE
American Society for Pharmacology and Experimental Therapeutics
RESUMO
The addition of calcineurin inhibitors, including cyclosporine A (CsA) and FK-506 (tacrolimus), to transplant protocols has markedly reduced acute allograft rejection and prolonged patient survival. Although monitoring of serum drug levels has been shown to be a poor indicator of efficacy, there is little data on calcineurin enzymatic activity in humans. Therefore, we measured calcineurin in isolated CD3+/4+ T cells from 81 non-transplant controls and 39 renal allograft patients by using a 32PO4-labeled calcineurin-specific substrate. A gender difference was observed in the control cohort, with activity in males significantly higher than that in females (1073 ± 134 versus 758 ± 75 fmol/μg/min, respectively). Activity of both groups was comparably inhibited by 5 ng/ml tacrolimus (27 ± 4 versus 30 ± 4%). Calcineurin is a downstream target of the T-cell receptor (TCR). Therefore, activity was measured in isolated T cells after incubation with anti-CD3/CD28 antibodies to stimulate the TCR. Calcineurin activity increased significantly from 1214 ± 111 to 1652 ± 138 fmol/μg/min; addition of either tacrolimus or CsA (500 ng/ml) blocked CD3/CD28 stimulation. Despite therapeutic levels of tacrolimus and CsA (mean 11.4 and 172 ng/ml), basal calcineurin activity was significantly higher among renal transplant recipients than controls (1776 ± 175 versus 914 ± 78 fmol/μg/min). In contrast, anti-CD3/CD28 antibodies failed to stimulate calcineurin activity in transplant subjects. Finally, we found that basal and stimulated calcineurin activities are inversely related. Consistent with this finding, basal activity in resting T cells rose over time after transplant but stimulation fell (r2 = 0.785, p < 0.05). These data suggest that examination of TCR-stimulated calcineurin activity after renal transplantation may be useful for monitoring immunosuppression of individual patients.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2713092Documentos Relacionados
- Receptor-stimulated death pathway is opened by antigen in mature T cells.
- Molecular model for receptor-stimulated calcium spiking.
- Mechanism of extracellular Ca2+ receptor-stimulated hormone release from sheep thyroid parafollicular cells.
- Basal and adenosine receptor-stimulated levels of cAMP are reduced in lymphocytes from alcoholic patients.
- T-cell receptor signaling is mediated by transient Lck activity, which is inhibited by inorganic mercury